Risperdal creator hit with $8B decision ; Johnson and Johnson
The offended party’s lawyers contended the antipsychotic sedate at the middle is connected to strange development of female bosom tissue in young men. PHILADELPHIA — A Philadelphia jury on Tuesday granted $8 billion in corrective harms against Johnson and Johnson and one if its auxiliaries over a medication the organizations made that the offended party’s…